Visual marker for determining compliance with a medication regimen

Details for Australian Patent Application No. 2002239927 (hide)

Owner DRUG ENHANCEMENT COMPANY OF AMERICA, L.L.C.

Inventors Griggs, Roger, D.; Gonzales, Gilbert, R.

Agent Spruson & Ferguson

Pub. Number AU-A-2002239927

PCT Pub. Number WO2002/056919

Priority 09/765,151 17.01.01 US

Filing date 17 January 2002

Wipo publication date 30 July 2002

International Classifications

A61K 049/00 Preparations for testing

Event Publications

13 February 2003 Application Open to Public Inspection

  Published as AU-A-2002239927

21 October 2004 Assignment before Grant

  Xanodyne Pharmacal, Inc. The application has been assigned to Pediamed Pharmaceuticals, Inc.

10 January 2008 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002239928-Apparatus and method of biometric identification or verification of individuals using optical spectroscopy

2002239926-Method of accessing data and logic on existing systems through dynamic construction of software components